Results 111 to 120 of about 40,518 (302)

Jason’s cloak in Apollonius Argonautica

Karanos
Jason’s shining arrival at Myrine, in Apollonius’ Argonautica, wearing a purple cloak and with a spear in the hand, highlights a glamorous heroic excellence that has its origin in Alexander the Great and evokes the military ceremonial mantles displayed ...
Alexandra Sousa
doaj   +1 more source

Sex, military occupation and rank are associated with risk of anterior cruciate ligament injury in tactical-athletes. [PDF]

BMJ Mil Health, 2023
Aguero AD, Irrgang JJ, MacGregor AJ, Rothenberger SD, Hart JM, Fraser JJ.   +5 more
europepmc   +1 more source

A Nightmare Revisited: The Resotration of the Canadian War Museum’s 8.8 cm Flak Gun [PDF]

, 2012
The German 8.8 cm Flugabwehrkanone (flak) gun is one of the most famous weapons of the Second World War. It was greatly feared by Allied soldiers and airmen alike.
Miller, Michael H.
core   +1 more source

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
Markers of neutrophil activation are increased in plasma during ALS, and markers of NET formation associate with ALS survival. ABSTRACT Objectives Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) inversely correlate with survival, suggesting a role for neutrophils in disease progression.
Lillia A. Baird, Haley McQuown, Jihyun Park, Samuel J. Teener, Ian F. Webber‐Davis, Andrew D. Carter, Dae‐Gyu Jang, Eva L. Feldman, Stephen A. Goutman, Benjamin J. Murdock   +9 more
wiley   +1 more source

The Gdańsk Landsknechts in the second half of the 16th century and their arms and armour

Fasciculi Archaeologiae Historicae, 2000
...
Marek Plewczyński
doaj  

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Introduction to the Study of Islamic Arms and Armours

Gladius, 1961
No disponible.
openaire   +4 more sources

A Targeted Approach to Improve Asthma Control Using Community Pharmacists. [PDF]

Front Pharmacol, 2021
Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, Bereznicki L, Mitchell B, Wilson F, Wright B, Wilson K, Weier N, Segrott R, Cleveland R, Jan S, Shan S, Billot L, Armour C.   +17 more
europepmc   +1 more source

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source

Editor's Preface [PDF]

, 2006
Rimer, Graeme
core   +1 more source